It's been a week since the release of a controversial study suggesting the popular diabetes drug Avandia increases the risk of heart attacks and heart deaths.
The Food and Drug Administration is convening a panel of experts to investigate, but there is at least one point on which most doctors appear to agree: The whole process of ensuring drug safety in this country is seriously flawed.
In an exclusive interview with ABC News, Dr. Janet Woodcock, deputy commissioner of the FDA, conceded:...
Full Story